KR20140041710A - 칼로리 제한 및 칼로리 제한 모방체의 마커 식별 - Google Patents

칼로리 제한 및 칼로리 제한 모방체의 마커 식별 Download PDF

Info

Publication number
KR20140041710A
KR20140041710A KR1020147000682A KR20147000682A KR20140041710A KR 20140041710 A KR20140041710 A KR 20140041710A KR 1020147000682 A KR1020147000682 A KR 1020147000682A KR 20147000682 A KR20147000682 A KR 20147000682A KR 20140041710 A KR20140041710 A KR 20140041710A
Authority
KR
South Korea
Prior art keywords
tissue
polynucleotide
subject
probe
genes listed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147000682A
Other languages
English (en)
Korean (ko)
Inventor
안젤라 마스탈로우디스
스티브 우드
토마스 알베르토 프롤라
제이미 루이스 바거
리차드 웨인드러크
조셉 창
Original Assignee
엔에스이 프로덕츠, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 엔에스이 프로덕츠, 인크. filed Critical 엔에스이 프로덕츠, 인크.
Publication of KR20140041710A publication Critical patent/KR20140041710A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
KR1020147000682A 2011-06-15 2012-06-15 칼로리 제한 및 칼로리 제한 모방체의 마커 식별 Withdrawn KR20140041710A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161497476P 2011-06-15 2011-06-15
US61/497,476 2011-06-15
PCT/US2012/042822 WO2012174484A2 (en) 2011-06-15 2012-06-15 Identifying markers of caloric restriction and caloric restriction mimetics

Publications (1)

Publication Number Publication Date
KR20140041710A true KR20140041710A (ko) 2014-04-04

Family

ID=47357787

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147000682A Withdrawn KR20140041710A (ko) 2011-06-15 2012-06-15 칼로리 제한 및 칼로리 제한 모방체의 마커 식별

Country Status (6)

Country Link
US (4) US20130178379A1 (https=)
EP (1) EP2721155A4 (https=)
JP (5) JP2014518071A (https=)
KR (1) KR20140041710A (https=)
CN (4) CN107217051A (https=)
WO (1) WO2012174484A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11345963B2 (en) 2018-05-07 2022-05-31 Ebay Inc. Nucleic acid taggants
CN113712121B (zh) * 2021-08-31 2023-08-15 河南牧业经济学院 尼克酰胺在改善泌乳期奶山羊乳成分中的应用
CN119700977B (zh) * 2024-12-11 2025-08-22 山东省妇幼保健院 Psmg4基因在制备心脏疾病治疗药物及相关诊断产品中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
PL363426A1 (en) * 2001-03-09 2004-11-15 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
CA2450126A1 (en) * 2001-06-26 2003-01-09 Wisconsin Alumni Research Foundation Gene expression alterations underlying the retardation of aging by caloric restriction in mammals
CA2477911A1 (en) * 2002-03-15 2003-09-25 Max F. Rothschild Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits
US20040191775A1 (en) * 2003-03-12 2004-09-30 Spindler Stephen R. Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics
ES2510690T3 (es) * 2004-12-17 2014-10-21 Alan B. Cash Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad
US7737158B2 (en) * 2005-10-11 2010-06-15 Washington University Processes for regulating blood glucose in a mammal
WO2007088046A2 (en) * 2006-02-01 2007-08-09 Nestec S.A. Nutritional system and methods for increasing longevity
WO2007109102A2 (en) * 2006-03-16 2007-09-27 Biomarker Pharmaceutical Methods for interventions and testing for caloric restriction (cr) mimetics
EP1956096A1 (en) * 2007-02-12 2008-08-13 Université Catholique de Louvain Method, device and kit for determining conditions related to a dysfunction of the renal proximal tubule
DK2279263T3 (da) * 2008-04-30 2013-11-11 Integrated Dna Tech Inc Rnase-h-baserede assays med anvendelse af modificerede rna-monomerer
WO2010005533A2 (en) * 2008-06-30 2010-01-14 The Johns Hopkins University Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
CA2754392A1 (en) * 2009-03-11 2010-09-16 Nestec S.A. Tissue-specific aging biomarkers
US20120094300A1 (en) * 2009-04-24 2012-04-19 Robin Shaw Bin1 as a Prognostic Marker in Cardiovascular Disease
JP2012115374A (ja) * 2010-11-30 2012-06-21 Kao Corp Ａｃａｃａ発現抑制方法

Also Published As

Publication number Publication date
JP6904676B2 (ja) 2021-07-21
WO2012174484A2 (en) 2012-12-20
JP2019037240A (ja) 2019-03-14
JP2021052803A (ja) 2021-04-08
EP2721155A4 (en) 2014-12-31
JP7355766B2 (ja) 2023-10-03
WO2012174484A3 (en) 2013-04-11
JP2016195613A (ja) 2016-11-24
US20160257996A1 (en) 2016-09-08
US20160186257A1 (en) 2016-06-30
JP2022113834A (ja) 2022-08-04
CN107217051A (zh) 2017-09-29
JP2014518071A (ja) 2014-07-28
CN113801878A (zh) 2021-12-17
US20130178379A1 (en) 2013-07-11
CN103732745A (zh) 2014-04-16
EP2721155A2 (en) 2014-04-23
CN121271860A (zh) 2026-01-06
US20160208330A1 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
US10718025B2 (en) Methods for predicting age and identifying agents that induce or inhibit premature aging
Gregg et al. Gene expression changes in children with autism
Steegenga et al. Sexually dimorphic characteristics of the small intestine and colon of prepubescent C57BL/6 mice
CN103710458A (zh) 预测抗tnf响应性或无响应性的生物标志物
JP2022113834A (ja) カロリー制限およびカロリー制限模倣物の同定用マーカー
Xu et al. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions
Barrey et al. Transcriptome analysis of muscle in horses suffering from recurrent exertional rhabdomyolysis revealed energetic pathway alterations and disruption in the cytosolic calcium regulation
WO2020061072A1 (en) Method of characterizing a neurodegenerative pathology
Daghestani et al. Global transcriptional profiling of granulosa cells from polycystic ovary syndrome patients: comparative analyses of patients with or without history of ovarian hyperstimulation syndrome reveals distinct biomarkers and pathways
US9732387B2 (en) Biomarker associated with irritable bowel syndrome and Crohn's disease
JP5990871B2 (ja) 疲労の判定方法
KR101814868B1 (ko) 마이크로 rna와 nmda 수용체의 상관관계를 이용한 해마의 기능감소 판단 방법, 기능감소 억제 방법 및 기능감소 억제제 스크리닝 방법
CN114075599A (zh) 单核苷酸多态性位点在制备代谢相关因素的遗传风险评分系统中的应用
WO2015168252A1 (en) Mitochondrial dna copy number as a predictor of frailty, cardiovascular disease, diabetes, and all-cause mortality
WO2004088274A2 (en) Psychoactive compound associated markers and method of use thereof
Martín-Climent et al. Single-cell transcriptomics and mouse model phenotyping for biomarker screen of peripheral blood biomarkers in Huntington’s disease
Matsakas Effect of exercise on the mRNA expression of growth factors, metabolic genes and myosin heavy chain isoforms in skeletal muscles of the rat
KR101402919B1 (ko) 중풍 분류용 뉴로펩타이드 ｙ 유전자 다형성 마커 및 이의 용도
CN102888451A (zh) 一种检测黄牛ppargc1a基因单核苷酸多态性的方法
WO2008041244A2 (en) A method for the identification of potential biomarkers and drug targets in brain plasticity related disorders
遺伝子発現プロファイルに基づく生理学的同等性 The Role of Transcriptomics: Physiological Equivalence Based on Gene Expression Profiles
Newman Lymphoblastoid cell lines as a model of human GRK3 transcriptional regulation
TW201625799A (zh) 治療憂鬱症和重度憂鬱症之方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140110

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid